Cardiff University is to play a major role in UK-wide research into antiviral drugs that could help protect people from the worst symptoms of the virus.
The University is working with Health and Care Research Wales and the Welsh Government to support the study, led by the University of Oxford.
Researchers at Oxford have been awarded funding by the National Institute for Health Research to carry out the work with colleagues at several UK universities, including Cardiff, and the NHS.
The PANORAMIC trial (Platform adaptive trial of novel antivirals for early treatment of COVID-19 in the community) will be the first clinical trial of its kind to test novel antiviral COVID-19 treatments for use early in the illness by people with COVID-19 in the community and who are at higher risk of complications.
